why choose us

First received: June 19, 2023

Clinical Trial: Genetic Testing of Cerebrospinal Fluid to Diagnose and Monitor Glioblastoma

Study Status: Completed

Recruit Status: RECRUITING

Condition: Glioblastoma

Study Type: OBSERVATIONAL


Official Title: Evaluating the Role of Cerebrospinal Fluid (CSF) Cell-free DNA (cfDNA) as a Prognostic Biomarker in Glioblastoma

Brief Summary: The goal of this study is to determine the utility of cerebrospinal fluid (CSF) cell-free DNA (cfDNA) as a prognostic biomarker in glioblastoma (GBM).

Read more